Navigation Links
Sanofi-aventis Announces a Good Third Quarter Performance; Increase in 2007 full-year earnings growth guidance
Date:10/31/2007

s States basis countries basis

Lovenox(R) 555 +7.4% 1,184 +14.3% 199 +13.1%

Plavix(R) 1,282 +6.5% 130 -13.3% 403 +23.6%

Lantus(R) 459 +18.6% 879 +30.6% 141 +48.4%

Taxotere(R) 610 +13.8% 522 +5.9% 266 +15.2%

Stilnox(R)/Ambien(R)/

Ambien CR(TM) 65 -9.7% 930 -22.9% 70 +4.5%

Eloxatin(R) 295 -33.0% 735 +9.1% 126 +8.6%

Copaxone(R) 240 +15.9% 613 +21.4% 44 +10.0%

Aprovel(R) 627 +5.4% - - 176 +18.1%

Allegra(R) 46 +7.0% 295 +9.7% 217 +24.0%

Tritace(R) 355 -8.5% 1 -91.7% 190 -34.7%

Amaryl(R) 90 -36.2% 6 -45.5% 195 +8.3%

Xatral(R) 126 -23.6% 79 +27.4% 44 +25.7%

Nasacort(R) 34 9.7% 172 +19.4% 21 +5.0%

Actonel(R) 153 -17.3% - - 86 +10.3%

Depakine(R) 161 +1.3% - - 75 +11.9%

Comments by product

Net sales of Lovenox(R), the leading low molecular weight heparin on the market, rose by 12.6% in the quarter to euro 633 million, boosted by its increased use in medical prophylaxis in the United States, where the product reported 14.6% growth in net sales to euro 384 million. In Europe and the "Other countries" region, the product posted growth of 9.7%.

In the United States, Lovenox(R) is now being sold in a new indication for the treatment of patients with acute ST-segment elevation myocardial infarction (STEMI), further enhancing the product's superiority over non- fractioned heparins. Application for approval for the same indication was filed in Europe in the last quarter of 2006.

One-yea
'/>"/>

SOURCE sanofi-aventis
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33

Related medicine news :

1. FDA Gives Green Signal To Sanofi-Aventis SAs Cancer Drug Taxotere
2. Sanofi-Aventis sets the ball rolling for trials of H7N1 bird flu vaccine
3. Sanofi-Aventis Allows Thais To Make Plavix
4. PM announces a new health care order for India
5. Ramdoss Announces Introduction of RCH-II
6. Britain Announces Third Transfusion Related Mad Cow Case
7. Gates Foundation Announces $287 Million In Grants Towards AIDS Vaccine
8. Tibet Announces the Dalai Lama’s Tour of South Americ
9. NHS announces further Cost cutting Measures
10. Indian PM Announces Of Setting Up India Study Center At Tashkent
11. PowderMed Announces Needle-Less Flu Vaccine
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/23/2014)... 2014 Mel Frank, also known as ... and harvesting marijuana. He is perhaps one of the ... he’ll be leading a special elective course on growing ... pm at Oaksterdam University in Oakland, California. ... nomenclature, harvesting and manicuring, and identifying preflowers and outdoor ...
(Date:9/23/2014)... September 23, 2014 Oaksterdam University has ... . In its first post, the University addresses the ... changing cannabis industry. , The cannabis industry is becoming ... is expecting an 18-month boost of more than $600 ... use pot sales. And, the new legal recreational marijuana ...
(Date:9/23/2014)... Mo. Infants, vocalizations throughout the first year ... and cooing to forming syllables and first words. ... amount of vocalizations may differ between hearing and ... that infant vocalizations are primarily motivated by infants, ... with profound hearing loss who received cochlear implants ...
(Date:9/23/2014)... 23, 2014 Florida Hospital Zephyrhills ... renovated Women’s Health Center on Wednesday, September 24. ... the specially designed center offers a new level ... County. The Women’s Health Center offers comprehensive women’s ... labor and delivery through The Baby Place®, and ...
(Date:9/23/2014)... 23, 2014 "The primary purpose of the ... an inventor from Sacramento, Ca.. "Call lights are often found ... hanging on the IV pole out of the patient's reach. ... call device whenever they need it, I created this caddy." ... the nurse call device within easy reach. The accessory ensures ...
Breaking Medicine News(10 mins):Health News:Special Elective Course Added to Oaksterdam University Schedule; Unique Opportunity to Learn From the “Godfather of Cannabis” Mel Frank on September 27, 2014 2Health News:Oaksterdam University Addresses "Why Quality Training Matters in a Growing Marijuana Industry" in First Blog Post 2Health News:Oaksterdam University Addresses "Why Quality Training Matters in a Growing Marijuana Industry" in First Blog Post 3Health News:Infant cooing, babbling linked to hearing ability, MU researcher finds 2Health News:Florida Hospital Zephyrhills Celebrates Grand Opening of Women’s Health Center 2Health News:Florida Hospital Zephyrhills Celebrates Grand Opening of Women’s Health Center 3
... cancer when it works with,the growth-promoting protein IL-3 and ... Tenn., Nov. 27 A gene called N-Myc,leads a ... is overexpressed,helping to trigger acute myeloid leukemia (AML) under ... conditions, according to,results of a mouse study done by ...
... CHAPEL HILL, N.C., Nov. 27 A story ... "colleague spam" -- the habit of,co-workers indiscriminately hitting ... New research by benchmarking leader Best Practices, LLC,uncovered ... spam" -- the,tendency of organizations to send redundant ...
... Failing Marks for Second Straight Year, WASHINGTON, Nov. ... Report Card on Lung Cancer. This,Report is an assessment ... state of Georgia. LCA-GA is a chapter of Lung ... patient support and,advocacy for people living with or at ...
... Nov. 27 The Aesthetic Extender,Symposium announced its inaugural ... which will be held in Miami Beach,Florida on October ... the first,and only event of its kind. Unlike other ... its mission statement a goal of adhering to,the policies ...
... Nov. 27 A new, free white ... on choosing the,right electronics manufacturing services (EMS) ... to download at, http://www.federalelec.com/medicalpaper ., Medical ... consistent quality and,conformance to product and regulatory ...
... E.S.T. - Positron emission tomography (PET) is a useful ... staging of lung cancer and improved treatment for patients, ... Journal of National Cancer Institute. , The ... of Cancer Care Ontarios Program in Evidence-Based Care led ...
Cached Medicine News:Health News:St. Jude Researchers Identify Key Genetic Trigger of Acute Myeloid Leukemia 2Health News:Using Efficient Communication to Boost Pharma Sales Force Productivity 2Health News:Lung Cancer Alliance-Georgia Issues Second Annual State-Specific Report Card on Lung Cancer 2Health News:Lung Cancer Alliance-Georgia Issues Second Annual State-Specific Report Card on Lung Cancer 3Health News:White Paper Details How to Choose the Right EMS Provider for Medical Products Outsourcing 2Health News:PET imaging significantly enhances standard imaging in lung cancer staging 2
(Date:9/23/2014)... 2014 Market Snapshot: Transcatheter Heart Valve 2007 to 2020 - ... , Italy , UK, Spain ) ... - Europe ( Germany , ... )" provides quantitative analysis of the transcatheter heart valves market in ... over the 2007–2020 period and key company share data by revenue in 2013 ...
(Date:9/23/2014)... , Sept. 23, 2014  SI-BONE, Inc., a ... iFuse Implant System, ® a minimally invasive surgical ... joint, today announced that the U.S. Patent and Trademark ... systems and methods for the fixation and fusion of ... fenestrated implant with a tapered distal end that may be placed from ...
(Date:9/23/2014)... IRVINE, Calif. , Sept. 23, 2014  Global ... technology to conquer some of the biggest healthcare challenges, ... simple and highly accurate blood test for the early ... the leading cause of cancer death. Typically, the symptoms ... advanced stage of cancer, where the chance of a ...
Breaking Medicine Technology:Market Snapshot: Transcatheter Heart Valve 2007 to 2020 - Europe (Germany, France, Italy, UK, Spain) 2SI-BONE, Inc. Strengthens Patent Portfolio with the U.S. Patent and Trademark Office's Issuance of Threaded, Fenestrated Implant Method Patent 2SI-BONE, Inc. Strengthens Patent Portfolio with the U.S. Patent and Trademark Office's Issuance of Threaded, Fenestrated Implant Method Patent 3Global Discovery Biosciences Announces Collaboration with IPMD, Inc. to Develop Innovative Aptamer-Based Blood Test for the Early Detection of Lung Cancer 2
... OctreoPharm Sciences GmbH, a Berlin-based specialist in nuclear ... received the worldwide exclusive license for the development ... The new Gallium-68-labeled radioactive contrast agent ... has the potential to selectively detect and monitor ...
... 2011 Avista Capital Partners, a leading private equity ... the departing Chief Executive Officer of Nycomed, as Healthcare ... the development of Nycomed during Avista,s ownership of the ... Limited for Euro 9.6 billion. Under Mr. ...
Cached Medicine Technology:OctreoPharm Sciences GmbH Granted Global and Exclusive License for Oncology Diagnostic Product 2Avista Capital Partners Appoints Hakan Bjorklund as Healthcare Operating Executive 2Avista Capital Partners Appoints Hakan Bjorklund as Healthcare Operating Executive 3
The Properdin ELISA Kit is approved for in-vitro diagnostic use and measurement of properdin serum levels, relevant in cases of recurrent meningococcal infection and recurrent bacterial meningitis....
Inquire...
... can be used for a variety of vacuum needs ... or volatile fumes., Quiet running operation ... changes forever , Chemically Resistant ... solvents such as acids and organics. ...
High-intensity 300-watt xenon lamp, with continuously adjustable output from 0 to 100% manually or automatically by camera video output signal....
Medicine Products: